Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P10721 (
c-kit
)
6,575
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We previously reported that the K562 cell line K562YO expressed a high level of the
c-kit
gene. In this study, we analyzed the mechanism of this expression and investigated the effects of the serine/threonine kinases such as protein kinase C (PKC) and cyclic adenosine 3',5'-monophosphate (cAMP)-dependent kinase (PKA) on it. The half-life of the
c-kit
mRNA in K562YO cells was greater than 10 hours, compared with 2 hours in the original K562 cells, which expressed a very low level of
c-kit
mRNA. This prolonged half-life can contribute to the high level of
c-kit
expression in K562YO cells. Cycloheximide (CHX), a protein synthesis inhibitor, caused increases in
c-kit
mRNA levels in K562YO cells. 12-O-tetradecanoylphorbol-13-acetate (TPA), by which PKC was activated at first and downregulated in a late phase, gradually decreased
c-kit
mRNA in K562YO cells until 9 hours and then returned to the control level 24 hours after treatment. TPA also rapidly decreased
c-kit
protein level on the membranes. In whole cells,
c-kit
protein was also decreased 6 hours after incubation with TPA. Calphostin C, a light-dependent PKC inhibitor, decreased
c-kit
mRNA levels within 30 minutes in a light-dependent manner. It also decreased
c-kit
protein in whole cells 2 hours after the addition. However, it increased the amount of
c-kit
protein on the cell surfaces.
Dibutyryl cyclic AMP
(dbc-AMP) increased
c-kit
mRNA as well as
c-kit
protein on membranes and in whole cells. Run-on transcriptional assay suggested that the agent (dbc-AMP) enhanced the transcription rate of the gene. These results suggest that
c-kit
protein on the membranes is downregulated by PKC activation and upregulated by PKC inhibition. In the whole cell lysate,
c-kit
proteins are decreased by PKC inhibition through downregulation of mRNA. On the other hand, the elevation of an intracellular cAMP level causes upregulation of both the mRNA and
c-kit
protein on membranes and in whole cells through enhanced transcription. Thus,
c-kit
gene expression is apparently modulated by PKC and PKA.
...
PMID:High expression of c-kit in K562YO cells due to the prolonged half-life of its mRNA: the effects of modification with serine/threonine kinase signals. 753 32